Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-02-28 @ 7:11 PM
Study NCT ID:
NCT00002960
Status:
COMPLETED
Last Update Posted:
2016-02-04
First Post:
1999-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-06
Start Date Type:
None
Primary Completion Date:
2000-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2000-07
Completion Date Type:
ACTUAL
First Submit Date:
1999-11-01
First Submit QC Date:
None
Study First Post Date:
2004-08-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-03
Last Update Post Date:
2016-02-04
Last Update Post Date Type:
ESTIMATED